ZYCLARA

This brand name is authorized in Austria, Canada, Estonia, Spain, Ireland, Lithuania, Netherlands, Poland, United Kingdom, United States

Active ingredients

The drug ZYCLARA contains one active pharmaceutical ingredient (API):

1 Imiquimod UNII P1QW714R7M - IMIQUIMOD

Imiquimod is an immune response modifier. Saturable binding studies suggest a membrane receptor for imiquimod exists on responding immune cells. Imiquimod has no direct antiviral activity. Read about Imiquimod

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZYCLARA Cream	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D06BB10	Imiquimod	D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06B Chemotherapeutics for topical use → D06BB Antivirals
Discover more medicines within D06BB10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02340445
Country: EE	Ravimiamet	Identifier(s): 1592995, 1593008, 1593019
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 12783002
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 217359, 369189
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1067334, 1067335, 1067336
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 132020
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100288038
Country: US	FDA, National Drug Code	Identifier(s): 99207-270, 99207-271, 99207-276